Predictors of good outcomes in patients with hepatocellular carcinoma (HCC) treated with transarterial radioembolization (TARE)

被引：0
|
作者：
Das, Parthib
Paul, Samuel
Min, Eric
Mittra, Arjun
Malalur, Pannaga G.
Manne, Ashish
机构：
[1] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
[2] Ohio State Univ, Coll Med, Columbus, OH USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16219
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Predictors of poor outcome for transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC).
    Prins, Petra
    Singh, Bhavana P.
    Armstrong, Samantha Ann
    He, Aiwu Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Thalidomide (Thal) tolerance in patients treated with transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)
    Goldenberg, A
    Volm, M
    Hochster, H
    Muggia, F
    Rosen, R
    Teperman, L
    Morgan, G
    Schwartz, J
    Sung, M
    Wadler, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 376S - 376S
  • [33] Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma
    Weng, Zhihong
    Ertle, Judith
    Zheng, Shaoping
    Lauenstein, Thomas
    Mueller, Stefan
    Bockisch, Andreas
    Gerken, Guido
    Yang, Dongliang
    Schlaak, Joerg F.
    ONCOLOGY LETTERS, 2013, 6 (06) : 1707 - 1712
  • [34] Long-term outcomes of Yttrium-90 transarterial radioembolization for patients with hepatocellular carcinoma
    Muglia, Riccardo
    De Giorgio, Massimo
    Marra, Paolo
    Carbone, Francesco Saverio
    Dulcetta, Ludovico
    Prussia, Carolina
    Loglio, Alessandro
    Ghirardi, Arianna
    Grikke, Laura Antra
    Bianchi, Claudia
    Poli, Gian Luca
    Gerali, Alberto
    Erba, Paola Anna
    Sironi, Sandro
    Fagiuoli, Stefano
    Vigano, Mauro
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [35] Outcomes of patients (pts) with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE): Global OPTIMIS final analysis.
    Peck-Radosavljevic, Markus
    Kudo, Masatoshi
    Raoul, Jean-Luc
    Lee, Han Chu
    Decaens, Thomas
    Heo, Jeong
    Lin, Shi-Ming
    Shan, Hong
    Yang, Yefa
    Bayh, Inga
    Nakajima, Keiko
    Cheng, Ann-Lii
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] Locoregional Transarterial Therapies for Hepatocellular Carcinoma: Transarterial Chemoembolization and Radioembolization
    Inarrairaegui, Mercedes
    D'Avola, Delia
    Sangro, Bruno
    VISZERALMEDIZIN, 2013, 29 (02): : 92 - 102
  • [37] TRANSARTERIAL CHEMOEMBOLIZATION VERSUS TRANSARTERIAL RADIOEMBOLIZATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
    Brown, Andrew
    Kassab, Ihab A.
    Chen, Vincent L.
    Townsend, Whitney A.
    Singal, Amit G.
    Parikh, Neehar D.
    HEPATOLOGY, 2019, 70 : 234A - 235A
  • [38] The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE)
    Quartuccio, Natale
    Ialuna, Salvatore
    Scalisi, Daniele
    D'Amato, Fabio
    Barcellona, Maria Rosa
    Bavetta, Maria Grazia
    Fusco, Giorgio
    Bronte, Enrico
    Musso, Emma
    Bronte, Fabrizio
    Picciotto, Viviana
    Carroccio, Antonio
    Verderame, Francesco
    Malizia, Giuseppe
    Cistaro, Angelina
    La Gattuta, Fabio
    Moreci, Antonino Maria
    CURRENT ONCOLOGY, 2024, 31 (03) : 1504 - 1514
  • [39] Transarterial Radioembolization for Hepatocellular Carcinoma Is Safe, but Is It Effective?
    Braillon, Alain
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 208 (06) : W241 - W241
  • [40] Transarterial radioembolization of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
    Helmberger, Thomas
    Pereira, Philippe L.
    RADIOLOGIE, 2022, 62 (03): : 234 - 238
12345